Mangoceuticals, Inc.
General ticker "MGRX" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $10.5M (TTM average)
Mangoceuticals, Inc. does not follow the US Stock Market performance with the rate: -10.3%.
Estimated limits based on current volatility of 10.3%: low 0.91$, high 1.20$
Factors to consider:
- Total employees count: 750 as of 2023
- Current price 44.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.29$, 3.53$]
- 2025-12-31 to 2026-12-31 estimated range: [1.01$, 2.77$]
Short-term MGRX quotes
Long-term MGRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.01MM | $0.73MM | $0.62MM |
| Operating Expenses | $2.00MM | $9.95MM | $8.59MM |
| Operating Income | $-1.99MM | $-9.22MM | $-7.97MM |
| Non-Operating Income | $-0.01MM | $0.01MM | $-0.73MM |
| Interest Expense | $0.01MM | $0.00MM | $0.01MM |
| Income(Loss) | $-2.00MM | $-9.21MM | $-8.71MM |
| Profit(Loss)* | $-2.00MM | $-9.21MM | $-8.71MM |
| Stockholders Equity | $0.61MM | $0.77MM | $13.95MM |
| Inventory | $0.00MM | $0.02MM | $0.00MM |
| Assets | $1.00MM | $1.05MM | $15.37MM |
| Operating Cash Flow | $-1.35MM | $-7.00MM | $-4.86MM |
| Capital expenditure | $0.04MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.04MM | $-0.00MM | $0.07MM |
| Financing Cash Flow | $2.05MM | $7.06MM | $4.13MM |
| Earnings Per Share** | $-1.73 | $-8.58 | $-4.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.